China Closed System Drug Transfer Device Market

ID: MRFR/Pharma/47921-HCR 200 Pages Vikita Thakur Last Updated: September 17, 2026
China Closed System Drug Transfer Device Market Research Report By Type (Membrane to Membrane, Needleless System), By Component (Vial Access Devices, Syringe Safety Devices, Accessories, Bag/Line Access Devices), By Closing Mechanism (Push to Turn System, Color-to-color Alignment System, Leur Lock Systems, Click to Lock Systems), By Technology (Compartmentalize Devices, Diaphragm-Based Devices, Air Filtration Devices), and By End-users (Hospitals & Clinics, Specialty Centers, Others) - Growth & Industry Forecast 2025 To 2035
China Closed System Drug Transfer Device Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)10.27%
2024 Market Size$ 72 Million
2025 Market Size$ 79.39 Million
2035 Market Size$ 211 Million
Key Players
Baxter International Inc
B. Braun Melsungen AG
Cardinal Health Inc
Cypress Medical Products LLC
ICU Medical Inc
Merit Medical Systems Inc
Trends
  • Regulatory Support and Compliance
  • Technological Advancements
  • Growing Demand from Healthcare Facilities
Opportunities
  • Government Initiatives and Funding
  • Increasing Focus on Patient Safety
  • Rising Incidence of Chronic Diseases
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Pharmaceutical, BY Type (USD Million)
      1. 4.1.1 Membrane-To-Membrane Systems
      2. 4.1.2 Needleless Systems
    2. 4.2 Pharmaceutical, BY Component (USD Million)
      1. 4.2.1 Vial Access Devices
      2. 4.2.2 Syringe Safety Devices
      3. 4.2.3 Bag/Line Access Devices
      4. 4.2.4 Accessories
    3. 4.3 Pharmaceutical, BY Closing Mechanism (USD Million)
      1. 4.3.1 Push To Turn System
      2. 4.3.2 Color-To-Color Alignment System
      3. 4.3.3 Luer Lock Systems
      4. 4.3.4 Click-To Lock System
    4. 4.4 Pharmaceutical, BY Technology (USD Million)
      1. 4.4.1 Compartmentalize Devices
      2. 4.4.2 Diaphragm-Based Devices
      3. 4.4.3 Air Filtration Devices
    5. 4.5 Pharmaceutical, BY End User (USD Million)
      1. 4.5.1 Hospitals & clinics
      2. 4.5.2 Specialty centers
      3. 4.5.3 Others
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Pharmaceutical
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Baxter International Inc (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 B. Braun Melsungen AG (DE)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Cardinal Health Inc (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Cypress Medical Products LLC (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 ICU Medical Inc (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Merit Medical Systems Inc (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Pall Corporation (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Terumo Corporation (JP)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 CHINA MARKET ANALYSIS BY TYPE
    3. 6.3 CHINA MARKET ANALYSIS BY COMPONENT
    4. 6.4 CHINA MARKET ANALYSIS BY CLOSING MECHANISM
    5. 6.5 CHINA MARKET ANALYSIS BY TECHNOLOGY
    6. 6.6 CHINA MARKET ANALYSIS BY END USER
    7. 6.7 KEY BUYING CRITERIA OF PHARMACEUTICAL
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF PHARMACEUTICAL
    10. 6.10 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
    12. 6.12 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
    13. 6.13 PHARMACEUTICAL, BY TYPE, 2024 (% SHARE)
    14. 6.14 PHARMACEUTICAL, BY TYPE, 2024 TO 2035 (USD Million)
    15. 6.15 PHARMACEUTICAL, BY COMPONENT, 2024 (% SHARE)
    16. 6.16 PHARMACEUTICAL, BY COMPONENT, 2024 TO 2035 (USD Million)
    17. 6.17 PHARMACEUTICAL, BY CLOSING MECHANISM, 2024 (% SHARE)
    18. 6.18 PHARMACEUTICAL, BY CLOSING MECHANISM, 2024 TO 2035 (USD Million)
    19. 6.19 PHARMACEUTICAL, BY TECHNOLOGY, 2024 (% SHARE)
    20. 6.20 PHARMACEUTICAL, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
    21. 6.21 PHARMACEUTICAL, BY END USER, 2024 (% SHARE)
    22. 6.22 PHARMACEUTICAL, BY END USER, 2024 TO 2035 (USD Million)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY COMPONENT, 2025-2035 (USD Million)
      3. 7.2.3 BY CLOSING MECHANISM, 2025-2035 (USD Million)
      4. 7.2.4 BY TECHNOLOGY, 2025-2035 (USD Million)
      5. 7.2.5 BY END USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

China Closed System Drug Transfer Device Market Segmentation

China Closed System Drug Transfer Device Market By Type (USD Million, 2025-2035)

  • Membrane-To-Membrane Systems
  • Needleless Systems

China Closed System Drug Transfer Device Market By Component (USD Million, 2025-2035)

  • Vial Access Devices
  • Syringe Safety Devices
  • Bag/Line Access Devices
  • Accessories

China Closed System Drug Transfer Device Market By Closing Mechanism (USD Million, 2025-2035)

  • Push To Turn System
  • Color-To-Color Alignment System
  • Luer Lock Systems
  • Click-To Lock System

China Closed System Drug Transfer Device Market By China Closed System Drug Transfer Device Market (USD Million, 2025-2035)

  • Compartmentalize Devices
  • Diaphragm-Based Devices
  • Air Filtration Devices

China Closed System Drug Transfer Device Market By End User (USD Million, 2025-2035)

  • Hospitals & clinics
  • Specialty centers
  • Others

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.